The organization’s primary objectives encompass
01
Development of evidence-based diagnostic criteria incorporating anthropometrically-adjusted cutoff values for muscle mass quantification, grip strength assessment, and functional performance metrics specific to Asian populations.
02
Implementation of knowledge dissemination strategies targeting healthcare practitioners, investigators, and health policy administrators regarding sarcopenia’s public health implications.
03
Facilitation of epidemiological and interventional studies examining sarcopenia’s prevalence, risk factors, and therapeutic approaches within Asian contexts.
04
Advancement of preventive strategies and clinical interventions, including resistance training protocols, nutritional optimization, and multimodal therapeutic approaches to mitigate sarcopenia’s functional impact.
05
Acceleration of therapeutic development through standardization of clinical trial designs, identification of novel molecular targets, and validation of pharmacological interventions specifically tailored for Asian populations’ genetic and physiological characteristics.
Through these population-specific initiatives, the AWGS contributes significantly to geriatric health optimization across Asian populations. Their work establishes standardized diagnostic frameworks while promoting evidence-based interventional strategies for maintaining musculoskeletal function in aging populations.
